Atlas Trials

A Trial to Evaluate the Abuse Potential of 3 Doses of GRT6005 in Adult Non-dependent Recreational Opioid Users

Clinical trial NCT03757559 · COMPLETED

Trial details

NCT number
NCT03757559
Sponsor
Tris Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Abuse, Drug
Start date
2013-04-15
Primary completion
2014-03-08
Enrollment
226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.